Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00JDJ
|
|||
| Drug Name |
AX-024
|
|||
| Synonyms |
VMMKGVRPILDZML-UHFFFAOYSA-N; SCHEMBL903258; AKOS030622922; CS-8052; HY-107390; 1370544-73-2
Click to Show/Hide
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 1 | [1] | |
| Company |
Artax Biopharma Cambridge, MA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H22FNO2
|
|||
| Canonical SMILES |
COC1=CC2=C(C=C1)OCC(=C2C3=CC=C(C=C3)F)CN4CCCC4
|
|||
| InChI |
1S/C21H22FNO2/c1-24-18-8-9-20-19(12-18)21(15-4-6-17(22)7-5-15)16(14-25-20)13-23-10-2-3-11-23/h4-9,12H,2-3,10-11,13-14H2,1H3
|
|||
| InChIKey |
VMMKGVRPILDZML-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NCK adaptor protein 1 (NCK1) | Target Info | Modulator | [1] |
| T-cells (T-cells) | Target Info | Inhibitor | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.